Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$146M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$129M |
| 3 |
TSMC
TSM
|
+$120M |
| 4 |
Monster Beverage
MNST
|
+$106M |
| 5 |
Mirion Technologies
MIR
|
+$93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$144M |
| 2 |
Advanced Micro Devices
AMD
|
+$134M |
| 3 |
Starbucks
SBUX
|
+$86.4M |
| 4 |
QuidelOrtho
QDEL
|
+$73.6M |
| 5 |
Humana
HUM
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.05% |
| 2 | Technology | 24.91% |
| 3 | Healthcare | 16.17% |
| 4 | Financials | 13.4% |
| 5 | Consumer Staples | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.79T
| $386M | 6.95% |
1,760,246
+233,427
| +15% | +$47.8M |
|
2
NVIDIA
NVDA
$5.2T
| $284M | 5.11% |
2,114,163
-253,928
| -11% | -$35M |
|
3
Microsoft
MSFT
$3.59T
| $263M | 4.74% |
624,277
+11,822
| +2% | +$5.04M |
|
4
Philip Morris
PM
$293B
| $255M | 4.59% |
2,119,221
+195,470
| +10% | +$24.7M |
|
|
5
TSMC
TSM
$2.17T
| $245M | 4.4% |
1,239,457
+622,478
| +101% | +$120M |
|
6
Natera
NTRA
$47.9B
| $216M | 3.89% |
1,366,054
+26,009
| +2% | +$3.79M |
|
7
LPL Financial
LPLA
$28.5B
| $192M | 3.45% |
587,721
+90,646
| +18% | +$26.8M |
|
8
GFL Environmental
GFL
$14.8B
| $168M | 3.03% |
3,778,606
+120,416
| +3% | +$5.24M |
|
|
9
Wells Fargo
WFC
$254B
| $150M | 2.7% |
+2,133,273
| New | +$146M |
|
|
VRNA
10
DELISTED
Verona Pharma
VRNA
| $145M | 2.61% |
3,128,516
-1,087,457
| -26% | -$40.8M |
|
|
11
Carnival Corporation Ltd
CCL
$35.2B
| $137M | 2.47% |
+5,499,782
| New | +$129M |
|
12
Astera Labs
ALAB
$49.4B
| $137M | 2.46% |
1,032,441
-123,789
| -11% | -$11.6M |
|
13
Visa
V
$693B
| $135M | 2.43% |
426,998
-65,261
| -13% | -$19.6M |
|
14
Southwest Gas
SWX
$6.44B
| $128M | 2.3% |
1,809,663
+44,515
| +3% | +$3.31M |
|
15
Nu Holdings
NU
$70.4B
| $127M | 2.29% |
12,294,266
+175,365
| +1% | +$2.33M |
|
16
DoorDash
DASH
$96.8B
| $123M | 2.21% |
733,674
-252,883
| -26% | -$41.5M |
|
17
lululemon athletica
LULU
$13.7B
| $122M | 2.19% |
318,514
-25,972
| -8% | -$8.48M |
|
18
Jones Lang LaSalle
JLL
$17.8B
| $113M | 2.03% |
445,091
-15,164
| -3% | -$4.04M |
|
|
19
Mirion Technologies
MIR
$3.69B
| $108M | 1.94% |
6,177,611
+5,994,184
| +3,268% | +$93M |
|
|
20
Monster Beverage
MNST
$93.6B
| $105M | 1.89% |
+3,986,040
| New | +$106M |
|
|
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
| $104M | 1.88% |
2,891,852
+113,504
| +4% | +$3.97M |
|
22
Wave Life Sciences
WVE
$1.04B
| $102M | 1.84% |
8,261,242
-1,786,278
| -18% | -$23.8M |
|
23
Vaxcyte
PCVX
$9.32B
| $98.4M | 1.77% |
1,201,898
+225,649
| +23% | +$22.4M |
|
|
24
Starbucks
SBUX
$122B
| $93.1M | 1.68% |
1,020,767
-893,565
| -47% | -$86.4M |
|
25
Apollo Global Management
APO
$78.4B
| $92.8M | 1.67% |
+561,604
| New | +$89M |
|
Similar funds
Lee Ainslie's Q4 2024 Portfolio in Review
As of Q4 2024, Lee Ainslie held 304 positions worth $5.56B, up 8.4% from $5.13B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Lee Ainslie's Q4 2024 filing shows 75 new, 47 increased, 100 reduced and 79 closed positions. Its largest new stake was Wells Fargo: 2,133,273 shares worth $150M. The largest sale was Coupang, an estimated $144M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- Lee Ainslie's largest Q4 2024 buy was Wells Fargo: 2,133,273 shares worth $150M.
- Lee Ainslie added most to TSMC in Q4 2024, an estimated $120M increase.
- Lee Ainslie's biggest Q4 2024 reduction was Coupang, cutting an estimated $144M.
- Lee Ainslie fully exited QuidelOrtho in Q4 2024, selling an estimated $73.6M.
- Lee Ainslie's ten largest holdings make up 41% of its $5.56B portfolio in Q4 2024.
- Lee Ainslie opened 75 new positions and closed 79 in Q4 2024.
- Lee Ainslie's portfolio value rose 8.4% quarter-over-quarter to $5.56B.
Based on Maverick Capital's 13F filing for Q4 2024, filed 14 Feb 2025.